|
DCF -Bewertung der Enovis Corporation (ENOV)
US | Industrials | Industrial - Machinery | NYSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Enovis Corporation (ENOV) Bundle
Möchten Sie den inneren Wert der Enovis Corporation beurteilen? Unser ENOV DCF-Taschenrechner integriert reale Daten mit umfassenden Anpassungsfunktionen, sodass Sie Ihre Prognosen verfeinern und Ihre Anlagestrategien verbessern können.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,070.8 | 3,854.3 | 1,563.1 | 1,707.2 | 2,107.6 | 2,101.0 | 2,094.4 | 2,087.8 | 2,081.3 | 2,074.7 |
| Revenue Growth, % | 0 | 25.52 | -59.45 | 9.22 | 23.46 | -0.31391 | -0.31391 | -0.31391 | -0.31391 | -0.31391 |
| EBITDA | 180.0 | 95.0 | 225.8 | 169.9 | -827.4 | -27.4 | -27.4 | -27.3 | -27.2 | -27.1 |
| EBITDA, % | 5.86 | 2.47 | 14.44 | 9.95 | -39.26 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 |
| Depreciation | 246.2 | 187.0 | 202.9 | 217.1 | -51.7 | 151.8 | 151.3 | 150.8 | 150.3 | 149.9 |
| Depreciation, % | 8.02 | 4.85 | 12.98 | 12.72 | -2.45 | 7.22 | 7.22 | 7.22 | 7.22 | 7.22 |
| EBIT | -66.2 | -92.0 | 22.9 | -47.2 | -775.7 | -179.2 | -178.6 | -178.1 | -177.5 | -177.0 |
| EBIT, % | -2.16 | -2.39 | 1.46 | -2.76 | -36.81 | -8.53 | -8.53 | -8.53 | -8.53 | -8.53 |
| Total Cash | 97.1 | 719.4 | 24.3 | 36.2 | 48.2 | 116.8 | 116.4 | 116.0 | 115.7 | 115.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 517.0 | 255.0 | 267.4 | 291.5 | .0 | 242.2 | 241.4 | 240.6 | 239.9 | 239.1 |
| Account Receivables, % | 16.84 | 6.61 | 17.11 | 17.07 | 0 | 11.53 | 11.53 | 11.53 | 11.53 | 11.53 |
| Inventories | 564.8 | 776.3 | 426.6 | 468.8 | 547.1 | 501.1 | 499.5 | 498.0 | 496.4 | 494.8 |
| Inventories, % | 18.39 | 20.14 | 27.29 | 27.46 | 25.96 | 23.85 | 23.85 | 23.85 | 23.85 | 23.85 |
| Accounts Payable | 330.3 | 155.2 | 135.6 | 132.5 | 179.1 | 166.9 | 166.4 | 165.8 | 165.3 | 164.8 |
| Accounts Payable, % | 10.75 | 4.03 | 8.68 | 7.76 | 8.5 | 7.94 | 7.94 | 7.94 | 7.94 | 7.94 |
| Capital Expenditure | -114.8 | -104.2 | -105.5 | -122.2 | -180.7 | -121.5 | -121.2 | -120.8 | -120.4 | -120.0 |
| Capital Expenditure, % | -3.74 | -2.7 | -6.75 | -7.16 | -8.57 | -5.78 | -5.78 | -5.78 | -5.78 | -5.78 |
| Tax Rate, % | -0.3123 | -0.3123 | -0.3123 | -0.3123 | -0.3123 | -0.3123 | -0.3123 | -0.3123 | -0.3123 | -0.3123 |
| EBITAT | -73.1 | -54.9 | 422.4 | -23.4 | -778.1 | -146.7 | -146.2 | -145.7 | -145.3 | -144.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -693.2 | -96.6 | 837.5 | 2.1 | -750.7 | -324.8 | -114.3 | -113.9 | -113.6 | -113.2 |
| WACC, % | 15.76 | 14.72 | 15.76 | 14.45 | 15.76 | 15.29 | 15.29 | 15.29 | 15.29 | 15.29 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -561.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -115 | |||||||||
| Terminal Value | -869 | |||||||||
| Present Terminal Value | -427 | |||||||||
| Enterprise Value | -988 | |||||||||
| Net Debt | 24 | |||||||||
| Equity Value | -1,013 | |||||||||
| Diluted Shares Outstanding, MM | 55 | |||||||||
| Equity Value Per Share | -18.32 |
What You Will Receive
- Comprehensive Financial Model: Enovis Corporation’s actual data facilitates accurate DCF valuation.
- Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates allow you to view results instantly as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation outputs.
- Adaptable and Repeatable: Designed for versatility, enabling ongoing use for in-depth forecasts.
Key Features
- Customizable Financial Inputs: Adjust essential metrics such as revenue growth, EBITDA %, and capital investments.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional financial metrics.
- High-Precision Accuracy: Leverages Enovis Corporation’s (ENOV) actual financial data for dependable valuation results.
- Effortless Scenario Analysis: Easily evaluate various assumptions and analyze results side by side.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download: Obtain the ready-to-use Excel file featuring Enovis Corporation’s (ENOV) financial data.
- Customize: Tailor forecasts, including revenue growth, EBITDA %, and WACC to your preferences.
- Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various projections and instantly compare the results.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Choose the Enovis Corporation (ENOV) Calculator?
- Accuracy: Utilizes real Enovis financials to ensure precise data.
- Flexibility: Built for users to easily test and adjust inputs as needed.
- Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
- User-Friendly: Designed for simplicity, making it accessible for those without extensive financial modeling skills.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessments related to Enovis Corporation (ENOV).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Enovis Corporation (ENOV) stock.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Healthcare Industry Enthusiasts: Gain insights into how companies like Enovis Corporation (ENOV) are valued in the healthcare market.
What the Template Contains
- Historical Data: Includes Enovis Corporation’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Enovis Corporation’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Enovis Corporation’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.